• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

    1/13/25 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email

    SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.



    Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solutions enable healthcare organizations to win loyalty and guide every patient to optimal care by leveraging hyper-personalized experiences.



    The combination of Upfront's patient acquisition and scheduling expertise with Health Catalyst's current robust patient engagement portfolio is expected to strengthen the patient experience foundation set by Twistle Patient Engagement by Health Catalyst™ and the Lumeon by Health Catalyst™ Care Orchestration platform, which both help patients stay informed throughout the care process.



    Health Catalyst also looks forward to integrating Upfront's technology into its offerings, as Upfront's technology analyzes clinical, sociodemographic, and patient-reported data to digitally guide patients to the care they need, helping care providers reengage patients, promote appointment attendance, streamline scheduling and referrals, and improve care transitions.



    Bolstered by the data foundation and deep analytical insights provided by Health Catalyst Ignite™ Data and Analytics, the combination of Upfront's technology and Health Catalyst Ignite™ will aim to help healthcare clients provide their patients with the best possible care.



    "We are excited to welcome the Upfront team and combine our mission-driven mindsets and patient experience capabilities. Guided by our commitment to igniting data-informed healthcare improvement with patient experience as a top priority, we are positioned to provide meaningful support to our clients for the patient care journey," said Health Catalyst CEO Dan Burton. "Fostering improved patient engagement and satisfaction is critical, and by adding Upfront to Health Catalyst's existing portfolio, we can better support our clients in their efforts to optimize access, improve care transitions, and close care gaps."



    "We're thrilled to join the Health Catalyst family," said Ben Albert, CEO and Co-founder at Upfront. "By combining Upfront's capabilities with Health Catalyst Ignite, we're creating a comprehensive solution to elevate patient engagement and activation. Together, we'll provide our clients with a single partner aiming to transform the patient experience and ensure every patient is guided to the care they need. We're looking forward to what's ahead."



    Health Catalyst plans to fund the transaction with a mix of cash and stock. Additional details regarding the acquisition were included in Health Catalyst's Form 8-K filed with the Securities and Exchange Commission ("SEC") on January 13, 2025.



    About Health Catalyst

    Health Catalyst (NASDAQ:HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.



    About Upfront Healthcare

    Upfront is a mission-driven healthcare company delivering tangible outcomes to leading healthcare systems and provider groups. Its patient engagement and access platform makes each patient feel seen, guiding their care experience through personalized outreach. The backbone of the Upfront experience is its data engine, which analyzes clinical, sociodemographic, and patient-reported data. These insights, along with its advanced psychographic segmentation model, allow Upfront to individually activate patients to get the care they need while building a meaningful relationship between the patient and their health system. Upfront is rooted in partnership, leveraging best-in-class healthcare expertise to maximize the impact of technology and deliver a next-generation patient experience.



    Forward-Looking Statements

    This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding Health Catalyst's ability to close and the timing of the closing of the acquisition of Upfront, its integration with Health Catalyst, and the benefits derived therefrom. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.

    (PRNewsfoto/Health Catalyst)

    Important risks and uncertainties that could cause actual results to differ materially from Health Catalyst's expectations, plans and prospects, including the benefits that will be derived from this transaction, include without limitation, conditions to closing the transaction not being satisfied, the risk of adverse and unpredictable macro-economic conditions, the potential impact on the business of Upfront due to the announcement of the transaction, and our ability to integrate Upfront into Health Catalyst's portfolio. For a detailed discussion of the risk factors that could affect Health Catalyst's actual results, please refer to the risk factors identified in Health Catalyst's SEC reports, including, but not limited to, the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024, filed with the SEC on November 6, 2024 and the Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 22, 2024. All information provided in this release and in the attachments is as of the date hereof, and Health Catalyst undertakes no duty to update or revise this information unless required by law.



    Media Contact:

    Amanda Flanders

    Senior Vice President of Marketing and Communications

    media@healthcatalyst.com

    808.743.1781

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-signs-definitive-agreement-to-acquire-upfront-healthcare-services-302348689.html

    SOURCE Health Catalyst

    Get the next $HCAT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    3/18/2026$1.00Overweight → Equal Weight
    Wells Fargo
    8/27/2025$4.00Overweight → Neutral
    Piper Sandler
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

    PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ:HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients. The transaction will augment Med-Metrix's technology-enable

    6/4/26 10:06:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

    SALT LAKE CITY, June 04, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced it has signed a definitive agreement to divest Vitalware, LLC and the Vitalware business unit, its mid-revenue cycle business, to Med-Metrix for a total consideration of $147 million in cash. This divestiture sharpens Health Catalyst's focus on driving measurable improvement for health systems across cost, clinical, and consumer performance, and the Company expects it to accelerate the broader transformation underway. "This is a big step forward for Health Catalyst. We are concentrating our business around the areas where we have the deepest conviction,

    6/4/26 9:03:29 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports First Quarter 2026 Results

    SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t

    5/11/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:46:49 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Chief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:46:28 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    6/3/26 7:45:28 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $HCAT
    SEC Filings

    View All

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Health Catalyst downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Health Catalyst from Overweight to Equal Weight and set a new price target of $1.00

    3/18/26 8:20:46 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/27/25 8:19:35 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    6/4/26 9:10:13 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form DEFA14A filed by Health Catalyst Inc

    DEFA14A - Health Catalyst, Inc. (0001636422) (Filer)

    6/3/26 5:23:42 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form DEF 14A filed by Health Catalyst Inc

    DEF 14A - Health Catalyst, Inc. (0001636422) (Filer)

    6/3/26 4:11:37 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors

    SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Steve Nelson, Executive Vice President and President of Aetna, a CVS Health company, has been appointed to its Board of Directors, effective May 1, 2026.  Nelson's appointment follows the naming of Ben Albert as CEO and Justin Spencer as Chairman of the Board earlier this year, continuing a deliberate pattern of leadership moves designed to accelerate the company's transformation– executing on a single, coordinated strategy to help health systems address cost, cli

    4/30/26 9:27:50 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.

    2/18/26 8:55:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

    SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o

    12/2/25 6:59:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports First Quarter 2026 Results

    SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. "We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, this quarter we took the first decisive step toward transforming our operating model and aligning the company around its highest-conviction technology opportunities. This is not a short-term cost exercise. It is a strategic reset designed t

    5/11/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

    SALT LAKE CITY, May 01, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 operating results on Monday, May 11, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ126." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    5/1/26 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Fourth Quarter and Year End 2025 Results

    SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2025. "We closed 2025 with solid performance across our business, including total revenue of $311.1 million and Adjusted EBITDA of $41.4 million," said Ben Albert, CEO of Health Catalyst "In 2026, we are focused on the future and on positioning Health Catalyst for long‑term success. As I continue to assess the business, I see both meaningful opportunities and clear areas where we must improve. I am confident in the

    3/12/26 4:05:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology